cyclosporine has been researched along with Kidney, Polycystic in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 6 (54.55) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersen, LK; Bygum, A; Jensen, JE | 1 |
Cassano, N; Vena, GA | 1 |
Diomedi-Camassei, F; Emma, F; Kengne-Wafo, S; Massella, L | 1 |
Pannu, HS; Sandhu, JS; Singh, D | 1 |
CarreƱo, CA; Gadea, M | 1 |
Kahan, BD; Podder, H | 1 |
Chuet, C; Finielz, P; Guiserix, J; Mondon, JM | 1 |
Hunt, KR; Lien, YH; Siskind, MS; Zukoski, C | 1 |
Brazda, E; Margreiter, R; Ofner, D; Riedmann, B; Spechtenhauser, B | 1 |
Bullorsky, E; Freixas, E; Pereyra, H; Rabinovich, O; Schropp, J; Trimarchi, H | 1 |
Cohen, SB; Kanter, ED; Kaplan, B; Myers-Powell, BA; Whitcup, SM; Yamani, A; Zarbin, MA | 1 |
11 other study(ies) available for cyclosporine and Kidney, Polycystic
Article | Year |
---|---|
Second episode of near-fatal angioedema in a patient treated with everolimus.
Topics: Angioedema; Cyclosporine; Everolimus; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Polycystic Kidney Diseases; Sirolimus | 2015 |
Etanercept treatment in a hemodialysis patient with severe cyclosporine-resistant psoriasis and hepatitis C virus infection.
Topics: Aged; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Etanercept; Follow-Up Studies; Hepatitis C; Humans; Immunoglobulin G; Injections, Subcutaneous; Kidney Failure, Chronic; Liver Function Tests; Male; Polycystic Kidney Diseases; Psoriasis; Receptors, Tumor Necrosis Factor; Renal Dialysis; Severity of Illness Index; Treatment Outcome | 2008 |
Idiopathic membranous nephropathy associated with polycystic kidney disease.
Topics: Biopsy; Child; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Hematuria; Humans; Immunosuppressive Agents; Kidney; Male; Nephrotic Syndrome; Polycystic Kidney Diseases; Prednisone; Renal Insufficiency; Severity of Illness Index; Treatment Outcome | 2010 |
Lipid profile before and after renal transplantation--a longitudinal study.
Topics: Adult; Azathioprine; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cyclosporine; Diabetic Nephropathies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glomerulonephritis; Graft Rejection; Humans; Hypercholesterolemia; Hypertension, Renal; Hypertriglyceridemia; Immunosuppressive Agents; Incidence; India; Kidney Failure, Chronic; Kidney Transplantation; Longitudinal Studies; Male; Nephrosclerosis; Polycystic Kidney Diseases; Prednisolone; Time Factors; Treatment Outcome; Triglycerides | 2003 |
Case report of a kidney transplant recipient converted to everolimus due to malignancy: resolution of bronchiolitis obliterans organizing pneumonia without everolimus discontinuation.
Topics: Adrenal Cortex Hormones; Azathioprine; Cryptogenic Organizing Pneumonia; Cyclosporine; Everolimus; Female; Humans; Kidney Transplantation; Methylprednisolone; Middle Aged; Papillomavirus Infections; Polycystic Kidney Diseases; Postoperative Complications; Sirolimus; Vaginal Neoplasms | 2007 |
Anesthetic rejection followed by surgical salvage.
Topics: ABO Blood-Group System; Adult; Creatinine; Cyclosporine; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Polycystic Kidney Diseases; Sirolimus; Treatment Outcome | 2006 |
Drug interaction between midecamycin and cyclosporin.
Topics: Cyclosporine; Drug Interactions; Female; Humans; Leucomycins; Middle Aged; Polycystic Kidney Diseases | 1995 |
Association of cyclosporin A with acquired cystic kidney disease of the native kidneys in renal transplant recipients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Cyclosporine; Female; Humans; Kidney Failure, Chronic; Kidney Neoplasms; Kidney Transplantation; Male; Middle Aged; Polycystic Kidney Diseases; Prospective Studies; Renal Dialysis | 1993 |
The effect of nephrectomy on the outcome of renal transplantation in patients with polycystic kidney disease.
Topics: Adolescent; Adult; Aged; Cause of Death; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Humans; Immunosuppressive Agents; Infant; Kidney Transplantation; Male; Middle Aged; Nephrectomy; Polycystic Kidney Diseases; Postoperative Complications; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome | 1996 |
Cyclosporine-associated thrombotic microangiopathy during daclizumab induction: a suggested therapeutic approach.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biomarkers; Blood Component Transfusion; Cyclosporine; Daclizumab; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Hemolysis; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Male; Microcirculation; Middle Aged; Plasmapheresis; Polycystic Kidney Diseases; Tacrolimus; Thrombosis | 2001 |
Visual loss after renal transplantation.
Topics: Blindness; Cyclosporine; Fluorescein Angiography; Fundus Oculi; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Polycystic Kidney Diseases; Retinal Artery Occlusion; Retinal Vein Occlusion; Retinal Vessels; Visual Acuity | 2001 |